Question to the Department for Business and Trade:

To ask His Majesty's Government what protections, if any, they have secured for the UK pharmaceutical industry in relation to the imposition of tariffs by the United States of America.

On 8 May, the UK government announced a landmark economic deal with the United States, making the UK the first country to get an agreement with President Trump.

The agreement will secure the UK preferential access to the US market for UK pharmaceuticals in case of new US tariffs being introduced in the future, further to any section 232 investigations. These conversations are ongoing, and we will work closely with the US administration to get the best deal for our pharma industry.